The EVOQUE Tricuspid Valve Replacement System is a pioneering transcatheter therapy designed to treat symptomatic severe tricuspid regurgitation (TR). It features a nitinol self-expanding frame, an intra-annular sealing skirt, and leaflets made from bovine pericardial tissue. The system offers three valve sizes, all deliverable via a 28F transfemoral delivery system, providing a minimally invasive alternative to traditional surgery. Clinical studies have demonstrated significant reduction or elimination of TR and notable improvements in patients' quality of life.